Shree Krishnakeshav Laboratories

Ahmedabad, India
Manufactures IV fluids, injections, and medical products for global healthcare providers.

About Shree Krishnakeshav Laboratories

Shree Krishnakeshav Laboratories is a Healthcare company based in Ahmedabad (India). It manufactures IV fluids, injections, and medical products for global healthcare providers. It operates on a B2B model. Its Indian entity Shree Krishnakeshav Laboratories Limited reported revenue of β‚Ή171 Cr. Shree Krishnakeshav Laboratories offers products and services including Dextrose Injection, Sodium Chloride Injection, Mannitol Injection, Metronidazole Injection, and Enoxaparin Sodium Injection. Its focus areas include Pharmaceuticals, IV Fluids, Injections and Veterinary Medicine.

Company details

Krishnakeshav Laboratories, established in 1964, produces a wide range of IV fluids and injections, including dextrose and sodium chloride solutions. Based in Ahmedabad, India, they prioritize quality and innovation in manufacturing processes to serve healthcare providers worldwide. With over 60 years of experience, they export to more than 50 countries and focus on sustainable packaging for medical products, ensuring safety and efficacy for patients.

Key Metrics
  • Annual Revenue
    ₹171 Cr

    FY 2025 · +13% YoY

  • Net Profit
    ₹22.08 Cr

    FY 2025 · 13% margin

  • EBITDA
    ₹34.04 Cr

    FY 2025 · 20% margin

Products & Services of Shree Krishnakeshav Laboratories

Shree Krishnakeshav Laboratories offers a comprehensive portfolio of products and services, including Dextrose Injection, Sodium Chloride Injection, Mannitol Injection, Metronidazole Injection, and Enoxaparin Sodium Injection.

Dextrose Injection
IV Fluid

Provides glucose for intravenous hydration and energy needs.

Sodium Chloride Injection
IV Fluid

Used for maintaining electrolyte balance in patients.

Mannitol Injection
IV Fluid

Administered for reducing intracranial pressure medically.

Metronidazole Injection
Antibiotic Injection

Treats bacterial and parasitic infections via infusion.

Enoxaparin Sodium Injection
Pre-Filled Syringe

Prevents blood clots in surgical and medical settings.

Board of directors of Shree Krishnakeshav Laboratories Limited (Shree Krishnakeshav Laboratories)

Shree Krishnakeshav Laboratories Limited is the primary company behind Shree Krishnakeshav Laboratories. The boards of the 2 registered companies of Shree Krishnakeshav Laboratories currently have 9 directors; the longest-serving is Vipul Abhechand Mehta, appointed in 2004. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vipul Abhechand Mehta
DIN 00155569
Managing Director01 Apr 200422 yrs 6 moShree Krishnakeshav Laboratories Limited
Kunal Atulbhai Mehta
DIN 00155594
Whole-time director01 Apr 200422 yrs 6 moShree Krishnakeshav Laboratories Limited
Kalpesh Dhirajlal Modi
DIN 01905085
Director25 Mar 200620 yrs 6 moShree Krishnakeshav Laboratories Limited
Umesh Abhechand Mehta
DIN 00157830
Whole-time director01 Apr 200620 yrs 6 moShree Krishnakeshav Laboratories Limited
Jitender Kumar Gupta
DIN 07583513
Director11 Aug 201610 yrs 2 moAllieva Pharma Private Limited
Geeta Gupta
DIN 07583516
Director11 Aug 201610 yrs 2 moAllieva Pharma Private Limited
Dharit Vipul Mehta
DIN 08584510
Whole-time director12 Oct 20197 yrsShree Krishnakeshav Laboratories Limited
Rushabh Bipinbhai Shah
DIN 10052088
Director20 Apr 20233 yrs 6 moShree Krishnakeshav Laboratories Limited
Jayesh Bhupendrabhai Dholakia
DIN 10360425
Additional Director17 Oct 20233 yrsShree Krishnakeshav Laboratories Limited

Financials of Shree Krishnakeshav Laboratories

Figures of Shree Krishnakeshav Laboratories Limited, the primary company behind Shree Krishnakeshav Laboratories, for FY 2025. Revenue was ₹171 Cr (+13% year on year). Net profit was ₹22.08 Cr (13% margin). EBITDA was ₹34.04 Cr (20% margin). Revenue has grown at a compounded annual rate of +8% over three years and +25% over five years.

  • ₹171 CrRevenue · FY 2025 · +13% YoY
  • ₹22.08 CrNet profit · 13% margin
  • ₹34.04 CrEBITDA · 20% margin
  • ₹99.8 LakhPaid-up capital
  • 192Employees (provident fund records)
  • +8%Revenue CAGR, 3 years
  • +25%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Shree Krishnakeshav Laboratories Limited are on its company page.

Premium access

Detailed financial statements for Shree Krishnakeshav Laboratories

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Shree Krishnakeshav Laboratories

Shree Krishnakeshav Laboratories is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

The primary company behind Shree Krishnakeshav Laboratories, Shree Krishnakeshav Laboratories Limited, reported revenue of β‚Ή171 Cr for FY 2025, up 13% year on year.

Krishnakeshav Laboratories, established in 1964, produces a wide range of IV fluids and injections, including dextrose and sodium chloride solutions. Based in Ahmedabad, India, they prioritize quality and innovation in manufacturing processes to serve healthcare providers worldwide. With over 60 years of experience, they export to more than 50 countries and focus on sustainable packaging for medical products, ensuring safety and efficacy for patients.

Shree Krishnakeshav Laboratories offers Dextrose Injection, Sodium Chloride Injection, Mannitol Injection, Metronidazole Injection, and Enoxaparin Sodium Injection.

Shree Krishnakeshav Laboratories is associated with 2 legal entities: Shree Krishnakeshav Laboratories Limited, Allieva Pharma Private Limited.

The legal entities of Shree Krishnakeshav Laboratories currently have 9 directors, including Jitender Kumar Gupta, Geeta Gupta, Umesh Abhechand Mehta and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available